Editor: Atta-ur-Rahman

Advances in Cancer Drug Targets

Volume 1

eBook: US $29 Special Offer (PDF + Printed Copy): US $133
Printed Copy: US $119
Library License: US $116
ISSN: 2451-8891 (Print)
ISSN: 2213-9915 (Online)
ISBN: 978-1-60805-601-9 (Print)
ISBN: 978-1-60805-474-9 (Online)
Year of Publication: 2013
DOI: 10.2174/97816080547561130101


Advances in Cancer Drug Targets is an e-book series that brings together recent expert reviews published on the subject with a focus on strategies for synthesizing and isolating organic compounds and elucidating the structure and nature of DNA. The reference work serves to give readers a brief yet comprehensive glance at current theory and practice behind employing chemical compounds for tackling tumor suppression, DNA site specific drug targeting and the inhibition of enzymes involved in growth control pathways. The reviews presented in this series are written by experts in pharmaceutical sciences and molecular biology. These reviews have been carefully selected to present development of new approaches to anti-cancer therapy and anti-cancer drug development. This e-book volume will be of special interest to molecular biologists and pharmaceutical scientists.


- Pp. i- (1)
Download Free

List of Contributors

- Pp. ii-v (4)
Download Free

The PIK3CA Gene as a Mutated Target for Cancer Therapy

- Pp. 3-21 (19)
Sarah Croessmann, Justin Cidado, John P. Gustin, David Cosgrove, Ben Ho Park
View Abstract

AKT Signaling in Regulating Angiogenesis

- Pp. 22-50 (29)
Bing-Hua Jiang, Ling-Zhi Liu
View Abstract

Inhibitors of Cyclin Dependent Kinases: Useful Targets for Cancer Treatment (An Update)

- Pp. 51-119 (69)
P. Sapra Sharma, R. Sharma
View Abstract

Cellular FLICE-Like Inhibitory Protein (c-FLIP): A Key Anti- Apoptotic Factor and a Target for Cancer Therapy

- Pp. 120-145 (26)
Ahmad R. Safa
View Abstract

Pin1: A Promising Novel Diagnostic and Therapeutic Target that Acts on Numerous Cancer-Driving Pathways

- Pp. 146-171 (26)
Greg Finn, Man-Li Luo, Xiao Zhen Zhou, Kun Ping Lu
View Abstract

Anticancer Immunotherapy in Combination with Proapoptotic Therapy - Possible Therapeutic Strategies for Enhancement of Anticancer Immune Reactivity in Autologous Immunocompetent Cells and After Allogeneic Stem Cell Transplantation

- Pp. 172-206 (35)
Håkon Reikvam, Elisabeth Ersvær, Guro Kristin Melve, Astrid Olsnes Kittang, Bjørn Tore Gjertsen, Øystein Bruserud
View Abstract

Melatonin and Breast Cancer: Selective Estrogen Enzyme Modulator Actions

- Pp. 207-237 (31)
Samuel Cos, Alicia González, Virginia Alvarez-García, Carolina Alonso-González, Carlos Martínez-Campa
View Abstract

Targeting Cancer and Neuropathy with Histone Deacetylase Inhibitors

- Pp. 238-263 (26)
V. Rodriguez-Menendez, L. Tremolizzo, G. Cavaletti
View Abstract


- Pp. 264-308 (45)
Download Free


.Potassium Channels as a Target for Clinical Therapeutics.